A carregar...
Immunosuppression in inflammatory bowel disease: how much is too much?
PURPOSE OF REVIEW: Current treatment approaches favor the early introduction of immunomodulators and/or antitumor necrosis factor (TNF) agents. There is now strong evidence showing that combination therapy appears to be more effective than monotherapy in both ulcerative colitis and Crohn’s disease....
Na minha lista:
| Publicado no: | Curr Opin Gastroenterol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6681654/ https://ncbi.nlm.nih.gov/pubmed/22573191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOG.0b013e328354567f |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|